Inventiva SA
PAR:IVA

Watchlist Manager
Inventiva SA Logo
Inventiva SA
PAR:IVA
Watchlist
Price: 2.76 EUR 1.66%
Market Cap: 264m EUR

P/OCF
Price to OCF

-3.1
Current
-5.5
Median
19.8
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-3.1
=
Market Cap
264m EUR
/
Operating Cash Flow
-84.7m EUR
Market Cap P/OCF
FR
Inventiva SA
PAR:IVA
264m EUR -3.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -228 295.9
US
Abbvie Inc
NYSE:ABBV
378.6B USD 20.1
US
Amgen Inc
NASDAQ:AMGN
170.3B USD 14.8
US
Gilead Sciences Inc
NASDAQ:GILD
139.9B USD 12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
132B USD -268
US
Epizyme Inc
F:EPE
94.1B EUR -492.8
AU
CSL Ltd
ASX:CSL
119.9B AUD 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.4B USD 16.8
US
Seagen Inc
F:SGT
39.3B EUR -79.5
NL
argenx SE
XBRU:ARGX
33.5B EUR -141
 
FR
Inventiva SA
PAR:IVA
Average P/OCF: 18.1
Negative Multiple: -3.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -228 295.9
US
Abbvie Inc
NYSE:ABBV
20.1
US
Amgen Inc
NASDAQ:AMGN
14.8
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -268
US
E
Epizyme Inc
F:EPE
Negative Multiple: -492.8
AU
CSL Ltd
ASX:CSL
25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -79.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -141

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A